cilostazol Tablets 100 mg
Dossier type
CTD
Dossier status
Ready to file
Country of origin
Indonesia
GMP approvals
Indonesia
Manufacturer #20982
This pharmaceutical company, based in Southeast Asia, has been operating for several decades. They are dedicated to providing quality prescription and over-the-counter medications, emphasizing research and development for continual innovation. They possess a global marketing network, distributing products worldwide, particularly in key regions like Southeast Asia, North America, and Europe. Their key therapeutic areas include cardiology, oncology, and infectious diseases, with a focus on solid dosage forms. The company holds several product patents and adheres to rigorous manufacturing standards, with facilities meeting EU and US GMP requirements.
Manufacturer usually replies in 8 days
Cilostazol is a medication used to treat intermittent claudication in peripheral vascular disease. Suppliers of cilostazol market it in the form of 50mg and 100mg tablets.
The drug was first introduced into the pharmaceutical market in 1999 and has since then become a widely prescribed medication with over a million prescriptions of cilostazol registered yearly in the U.S. alone. The largest manufacturers of cilostazol globally include GlaxoSmithKline, Bristol-Myers Squibb, Bedford Laboratories, Takeda, Novartis, Mylan, Abbot, and Pfizer.
Cilostazol suppliers and distributors market both generic and trade name formulations of the drug. Buyers are advised that online sellers may attempt to market fraudulent versions of the generic drug, whereas Pipeline Pharma, through its pre-auditing and quality control procedures ensures that only verified cilostazol manufacturers and wholesalers enter our online marketplace, offering you a risk-free B2B pharmaceutical sales platform.
The retail prices per 56 (100mg) tablets of cilostazol fall into an approximate range of 15,00 EUR to 20,00 EUR.